Compare Indoco Remedies with CENTURY PLYBOARDS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs CENTURY PLYBOARDS - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES CENTURY PLYBOARDS INDOCO REMEDIES/
CENTURY PLYBOARDS
 
P/E (TTM) x 135.5 20.8 652.3% View Chart
P/BV x 2.3 3.9 57.9% View Chart
Dividend Yield % 0.6 0.7 90.4%  

Financials

 INDOCO REMEDIES   CENTURY PLYBOARDS
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
CENTURY PLYBOARDS
Mar-18
INDOCO REMEDIES/
CENTURY PLYBOARDS
5-Yr Chart
Click to enlarge
High Rs317363 87.4%   
Low Rs178236 75.6%   
Sales per share (Unadj.) Rs113.191.1 124.1%  
Earnings per share (Unadj.) Rs4.57.5 59.7%  
Cash flow per share (Unadj.) Rs11.811.6 102.2%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Dividend yield (eoy) %0.40.3 120.8%  
Book value per share (Unadj.) Rs73.238.3 191.1%  
Shares outstanding (eoy) m92.15222.17 41.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.23.3 66.7%   
Avg P/E ratio x55.540.0 138.6%  
P/CF ratio (eoy) x21.025.9 81.0%  
Price / Book Value ratio x3.47.8 43.3%  
Dividend payout %22.413.4 167.4%   
Avg Mkt Cap Rs m22,83066,484 34.3%   
No. of employees `0005.57.1 76.7%   
Total wages/salary Rs m2,2093,129 70.6%   
Avg. sales/employee Rs Th1,910.12,844.2 67.2%   
Avg. wages/employee Rs Th405.0439.7 92.1%   
Avg. net profit/employee Rs Th75.5233.5 32.3%   
INCOME DATA
Net Sales Rs m10,41920,239 51.5%  
Other income Rs m4779 59.6%   
Total revenues Rs m10,46620,318 51.5%   
Gross profit Rs m1,3493,311 40.8%  
Depreciation Rs m677907 74.7%   
Interest Rs m235358 65.6%   
Profit before tax Rs m4842,124 22.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m72463 15.6%   
Profit after tax Rs m4121,661 24.8%  
Gross profit margin %12.916.4 79.2%  
Effective tax rate %15.021.8 68.6%   
Net profit margin %4.08.2 48.1%  
BALANCE SHEET DATA
Current assets Rs m5,3738,458 63.5%   
Current liabilities Rs m4,1576,753 61.6%   
Net working cap to sales %11.78.4 138.5%  
Current ratio x1.31.3 103.2%  
Inventory Days Days6869 98.1%  
Debtors Days Days7364 113.0%  
Net fixed assets Rs m6,2447,736 80.7%   
Share capital Rs m184223 82.8%   
"Free" reserves Rs m6,5668,293 79.2%   
Net worth Rs m6,7508,516 79.3%   
Long term debt Rs m1,2331,669 73.8%   
Total assets Rs m12,36317,254 71.6%  
Interest coverage x3.16.9 44.1%   
Debt to equity ratio x0.20.2 93.2%  
Sales to assets ratio x0.81.2 71.9%   
Return on assets %5.211.7 44.7%  
Return on equity %6.119.5 31.3%  
Return on capital %9.024.4 37.0%  
Exports to sales %04.5 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA903 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,762903 416.5%   
Fx outflow Rs m1,1435,048 22.6%   
Net fx Rs m2,619-4,145 -63.2%   
CASH FLOW
From Operations Rs m1,2273,046 40.3%  
From Investments Rs m-1,360-2,504 54.3%  
From Financial Activity Rs m-388-1,003 38.7%  
Net Cashflow Rs m-521-461 112.9%  

Share Holding

Indian Promoters % 59.2 74.5 79.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 2.0 631.3%  
FIIs % 6.0 5.9 101.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 17.7 126.6%  
Shareholders   12,805 12,161 105.3%  
Pledged promoter(s) holding % 0.0 8.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   KOTHARI PRODUCTS  INGERSOLL RAND  FINOLEX INDUSTRIES  INDIABULLS FIN. SER.  STC INDIA  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

CENTURY PLYBOARDS Announces Quarterly Results (1QFY20); Net Profit Up 6.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CENTURY PLYBOARDS has posted a net profit of Rs 481 m (up 6.1% YoY). Sales on the other hand came in at Rs 6 bn (up 6.8% YoY). Read on for a complete analysis of CENTURY PLYBOARDS's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

CENTURY PLYBOARDS Announces Quarterly Results (4QFY19); Net Profit Down 4.4% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, CENTURY PLYBOARDS has posted a net profit of Rs 342 m (down 4.4% YoY). Sales on the other hand came in at Rs 6 bn (up 7.2% YoY). Read on for a complete analysis of CENTURY PLYBOARDS's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Sep 13, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS